ES2191842T3 - Interleucina-8 como agente antiviral y antitumoral. - Google Patents

Interleucina-8 como agente antiviral y antitumoral.

Info

Publication number
ES2191842T3
ES2191842T3 ES97929060T ES97929060T ES2191842T3 ES 2191842 T3 ES2191842 T3 ES 2191842T3 ES 97929060 T ES97929060 T ES 97929060T ES 97929060 T ES97929060 T ES 97929060T ES 2191842 T3 ES2191842 T3 ES 2191842T3
Authority
ES
Spain
Prior art keywords
agent
interleucina
antiviral
hiv
caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97929060T
Other languages
English (en)
Inventor
Jean Gosselin
Pierre Borgeat
Bassam Damaj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virocell Inc
Original Assignee
Virocell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virocell Inc filed Critical Virocell Inc
Application granted granted Critical
Publication of ES2191842T3 publication Critical patent/ES2191842T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL USO DE UN AGENTE DE INTERLEUCINA - 8 (IL - 8) PARA EL TRATAMIENTO DE INFECCIONES VIRALES, PROVOCADAS POR VIRUS HUMANOS Y ANIMALES, Y DEL CANCER CAUSADO POR ONCOVIRUS. EL AGENTE IL - 8 PUEDE SER UNA PROTEINA IL - 8 O UN ANALOGO DE LA MISMA QUE TENGA UNA ACTIVIDAD BIOLOGICA IL - 8. LA INFECCION VIRICA PODRIA CORRESPONDER A UN VIRUS DEL DNA, SELECCIONADO ENTRE EL GRUPO FORMADO POR LOS PARVOVIRIDAE, PAPOVARIDAE, ADENOVIRIDAE, HERPES - VIRIDAE, POXVIRIDAE Y HEPADNAVIRIDAE, O DE UN VIRUS DEL RNA SELECCIONADO ENTRE EL GRUPO FORMADO POR LOS RETROVIRIDAE, EXCLUIDOS LOS VIH - 1 Y VIH - 2, PICORNAVIRIDAE, TOGAVIRIDAE, ORTHOMYXOVIRIDAE, PARAMYXOVIRIDAE, CORONAVIRIDAE, REOVIRIDAE, ONCORNAVIRIDAE Y FILOVIRIDAE.
ES97929060T 1996-07-05 1997-07-04 Interleucina-8 como agente antiviral y antitumoral. Expired - Lifetime ES2191842T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/674,633 US5900235A (en) 1996-07-05 1996-07-05 Interleukin-8 as an antiviral and antitumor agent

Publications (1)

Publication Number Publication Date
ES2191842T3 true ES2191842T3 (es) 2003-09-16

Family

ID=24707360

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97929060T Expired - Lifetime ES2191842T3 (es) 1996-07-05 1997-07-04 Interleucina-8 como agente antiviral y antitumoral.

Country Status (12)

Country Link
US (1) US5900235A (es)
EP (1) EP0909178B1 (es)
JP (1) JP2000514066A (es)
KR (1) KR20000023562A (es)
AT (1) ATE232108T1 (es)
AU (1) AU713675B2 (es)
BR (1) BR9710206A (es)
CA (1) CA2258697A1 (es)
DE (1) DE69718911T2 (es)
ES (1) ES2191842T3 (es)
NZ (1) NZ333605A (es)
WO (1) WO1998001150A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962971B2 (en) * 2001-03-16 2005-11-08 The Regents Of The University Of California Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
JP4686189B2 (ja) * 2002-10-24 2011-05-18 パラテック ファーマシューティカルズ インコーポレイテッド Ｒｎａを調節するための置換テトラサイクリン化合物の使用方法
JPWO2005051405A1 (ja) * 2003-11-25 2007-06-14 株式会社カネカ Ｉｌ−８産生促進剤とその用途
KR20230086610A (ko) 2021-12-07 2023-06-15 재단법인 아산사회복지재단 Il-12를 발현하는 재조합 백시니아 바이러스 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3681795A (en) * 1994-09-23 1996-04-09 University Of Nebraska Board Of Regents Polypeptide agonists and antagonists of human interleukin-8

Also Published As

Publication number Publication date
NZ333605A (en) 2000-12-22
BR9710206A (pt) 1999-08-10
EP0909178B1 (en) 2003-02-05
EP0909178A1 (en) 1999-04-21
CA2258697A1 (en) 1998-01-15
KR20000023562A (ko) 2000-04-25
DE69718911D1 (de) 2003-03-13
JP2000514066A (ja) 2000-10-24
AU3331497A (en) 1998-02-02
ATE232108T1 (de) 2003-02-15
DE69718911T2 (de) 2003-12-24
AU713675B2 (en) 1999-12-09
US5900235A (en) 1999-05-04
WO1998001150A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
ES2066782T3 (es) Tratamiento de infecciones virales humanas mediante arn bicatenario combinado con inhibidores virales.
BR9707535A (pt) Utilização de uma quantidade farmacologicamente aceitável e terapeuticamente eficaz de um agente leucotrieno b4 (ltb4) e composição farmacêutica.
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
BR9710355A (pt) Composição útil para o tratamento de infecções virais em um mamìfero, processo para tratar uma infecção viral em um mamìfero, e, produto medicinal.
ES2052591T3 (es) Variantes de virus lav, sus componentes de adn y de proteinas, y sus utilizaciones particularmente con fines diagnosticos y para la preparacion de composiciones inmunogenicas.
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
HUP0003384A2 (hu) Legalább egy, kettős szálú RNS és legalább egy, vírus elleni szer kombinációját tartalmazó termék
ECSP077252A (es) Métodos para tratar la hepatitis C
WO2007033444A3 (en) Antiviral therapy with carbohydrate binding agents
ES2058898T3 (es) Compuesto farmaceutico, util a titulo preventivo o curativo contra los tumores inducidos por los papilomavirus.
BR0108499A (pt) Agente terapêutico para hepatite c
ATE442155T1 (de) Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids
ES2191842T3 (es) Interleucina-8 como agente antiviral y antitumoral.
WO2006045616A3 (en) β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES
Lim et al. Photoinactivation of vesicular stomatitis virus by a photodynamic agent, chlorophyll derivatives from silkworm excreta
MXPA02011969A (es) Metodos para el tratamiento de padecimientos virales con il-18 y combinaciones de il-18.
ATE478679T1 (de) Verfahren zur anwendung von ionisierungsstrahlung bei einer hiv-infektionstherapie
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
LT2003008A (en) Parapox ovis virus for use against organ fibrosis
ES2058116T3 (es) El virus varicella-zoster como una vacuna recombinante viva.
BR112019017855A8 (pt) Compostos, composição farmacêutica compreendendo os ditos compostos, usos dos mesmos para tratar o vírus da hepatite b e o vírus da imunodeficiência humana e processo para a preparação dos ditos compostos
CA2244078A1 (en) Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents
DK0685235T3 (da) Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem
IT1212737B (it) Derivati pirimidinici ad azione antivirale.
ATE210990T1 (de) Therapeutischer viraler wirkstoff, welcher das fortschreiten von tumoren stoppt